Call to Action References
Surgeon General's Call to Action to Prevent Suicide, 1999
1. Peters KD, Kochanek KD, Murphy SL. Deaths: final data for 1996. In: CDC.
National vital statistics reports, vol. 47, no. 9. Hyattsville, Maryland:
National Center for Health Statistics, 1998.
2. McCraig LF, Strussman BJ. National Hospital Ambulatory Care Survey: 1996. In:
CDC. Emergency department summary. Advance Data from Vital and Health
Statistics, no. 293. Hyattsville, Maryland: National Center for Health
3. Conwell Y, Brent D. Suicide and aging I: patterns of psychiatric diagnosis.
Int Psychogeriatr 1995;7:149-64.
4. Harris EC, Barraclough BB. Suicide as an outcome for mental disorders. Br J
Psychiatry 1997; 170:205-28.
5. Murray CJL, Lopez, AD. The global burden of disease, vol. I. Boston: Harvard
School of Public Health, 1996.
6. Ness DE, Pfeffer CR. Sequelae of bereavement resulting from suicide.
Am J Psychiatry 1990; 147: 279-85.
7. World Health Organization. Prevention of suicide: guidelines for the
formulation and implementation of national strategies. Geneva: World Health
8. Mó´scicki EK, O’Carroll P, Regier DA, Rae DS, Roy A, Locke BZ. Suicide
attempts in the Epidemiologic Catchment Area Study. Yale J Biol Med
9. Kachur S, Potter L, James S, Powell K. Suicide in the United States,
1980-1992. Violence Surveillance Summary Series, no. 1. Atlanta: CDC, National
Center for Injury Prevention and Control, 1995.
10. Centers for Disease Control. (1988). National mortality statistics
11. CDC. Suicide among children, adolescents, and young adults—United States,
1980-1992. MMWR Morb Mortal Wkly Rep 1995; 44(15):289-91.
12. CDC. Ten leading causes of death for the United States. Available at:
13. Carney SS, Rich CL, Burke PA, Fowler RC. Suicide over 60: the San Diego
study. J Am Geriatr Soc 1994;42:174-80.
14. Dorpat TL, Anderson WF, Ripley HS. The relationship of physical illness to
suicide. In: Resnik HP, editor. Suicide behaviors: diagnosis and management.
Boston: Little, Brown, 1968:209-19.
15. Pearson JL, Conwell Y, Lyness JM. Late-life suicide and depression in the
primary care setting. In: Schneider LS, editor. Developments in geriatric
psychiatry. New directions for mental health services (no. 76). San Francisco:
16. Wallace LJD, Calhoun AD, Powell KE, O’Neil J, James SP. Homicide and suicide
among Native Americans, 1979-1992. Violence Surveillance Summary Series, no. 2.
Atlanta: CDC, National Center for Injury Prevention and Control, 1996.
17. Indian Health Service. Trends in Indian Health 1997. Available at
18. CDC. Suicide among black youths, United States, 1980-1995. MMWR Morb Mortal
Wkly Rep 1998;47(10):193-6.
19. Clark DC, Horton-Deutsch SL. Assessment in absentia: the value of
psychological autopsy method for studying antecedents of suicide and predicting
future suicides. In: Maris RW, Berman AL, Maltsberger JT, Yufit RI, editors.
Assessment and prediction of suicide. New York: Guilford, 1992:144-181.
20. Gibbs J.T. Conceptual, methodological, and sociocultural issues in black
youth suicide: Implications for assessment and early intervention. Suicide Life
Threat Behav 1988;18(1):73-89.
21. O’Carroll PW. Validity and reliability of suicide mortality data. Suicide
Life Threat Beh 1989;19:1-16.
22. Jamison, K, Baldessarini RJ, editors. Effects of medical interventions on
suicidal behavior. J Clin Psychiatry 1999;60(suppl 2):4-6,117-22.
23. Brent DA, Kolko DJ, Birhamer B, et al. Predictors of treatment efficacy in a
clinical trial of three psychosocial treatments for adolescent depression. J Am
Acad Child Adolesc Psychiatry 1998;37:906-14.
24. Cornelius JR, Salloum IM, Cornelius MD, et al. Fluoxetine trial in suicidal
depressed alcoholics. Psychopharmacol Bull 1993;29:195-9.
25. Evans K, Tyrer P, Catalan J, et al. Manual-assisted cognitive behaviour
therapy (MACT): a randomized controlled trial of brief intervention with
bibliotherapy in the treatment of deliberate self-harm. Psychol Med
26. Hawton K, Arensman E, Townsend E, et al. Deliberate self harm: systematic
review of efficacy of psychosocial and pharmacological treatments in preventing
repetition. Br Med J 1998;317:441-7.
27. Linehan MM, Heard HL, Armstrong HE. Naturalistic follow-up of a behavioral
treatment for chronically parasuicidal borderline patients. Arch Gen Psychiatry
28. Meltzer HY, Okayli G. Reduction in suicidality during clozapine treatment of
neuroleptic-resistant schizophrenia: impact on risk-benefit assessment. Am J
29. Rhimer Z, Rutz W, Pihlgren H. Depression and suicide on Gotland: an
intensive study of all suicides before and after a depression-training programme
for general practitioners. J Affective Disord 1995;35:147-52.
30. Verkes RJ, Van der Mast RC, Hengevold VW, et al. Reduction by paroxetine of
suicidal behavior in patients with repeated suicide attempts but not major
depression. Am J Psychiatry 1998;155:543-7.
31. Blumenthal SJ. Suicide: a guide to risk factors, assessment, and treatment
of suicidal patients. Med Clin North Am 1988;72:937-71.
32. Jenkins R. Principles of prevention. In: Paykel ES, Jenkins R, editors.
Prevention in psychiatry. London: Gaskell,1994:11-24.
33. Silverman MM, Felner RD. Suicide prevention programs: issues of design,
implementation, feasibility, and developmental appropriateness. Suicide Life
Threat Behav 1995; 25: 92-103.
34. Blumenthal SJ, Kupfer DJ, editors. Suicide over the life cycle. Washington,
DC: American Psychiatric Press, 1990.
35. Gibbs JT. African-American suicide: a cultural paradox. Suicide Life Threat
Behav 1997; 27: 68-79.
36. Mann JJ. The neurobiology of suicide. Nat Med 1988;4:25-30.
37. Mo´scicki EK. Epidemiology of suicide. In: Jacobs DG, editor. Harvard
Medical School guide to suicide assessment and intervention. San Francisco:
38. Roberts RE, Chen YR, Roberts CR. Ethnocultural differences in prevalence of
adolescent suicidal behaviors. Suicide Life Threat Behav 1997;27(2):208-17.
39. Stoff DM, Mann JJ, editors. The neurobiology of suicide. Ann NY Acad Sci
40. Henriksson M, Marttunen M, Heikkinen M, et al. Mental disorders and
comorbidity in suicide. Am J Psychiatry 1993;150:935.
41. Cornelius JR, Salloum IM, Mezzich J, et al. Disproportionate suicidality in
patients with comorbid major depression and alcoholism. Am J Psychiatry
42. Brent DA, Johnson BA, Perper J, et al. Personality disorder, personality
traits, impulsive violence, and completed suicide in adolescents. J Am Acad
Child Adolesc Psychiatry 1994;33(8):1080-6.
43. Isacsson G, Holmgren P, Druid H, Bergman U. The utilization of
antidepressants: a key issue in the prevention of suicide: an analysis of 5281
suicides in Sweden during the period 1992-1994. Acta Psychiatrica Scandinavia
44. Oquendo MA, Malone KM, Ellis SP, Sackeim HA, Mann JJ. Inadequacy of
antidepressant treatment for patients with major depression who are at risk for
suicidal behavior. Am J Psychiatry 1999;156:190-4.
45. Vieland V, Whittle B, Garland A, et al. The impact of curriculum-based
suicide prevention programs for teenagers: an eighteen–month follow-up. J Am
Acad Child Adolesc Psychiatry 1991;30:811-5.
46. O’Carroll PW, Potter LB. Suicide contagion and the reporting of suicide:
Recommendations from a national workshop. MMWR 1994;43(No. RR-6): 9-18.
47. Gould M. Suicide clusters and media exposure. In: Blumenthal SJ, Kupfer DJ,
editors. Suicide over the life cycle. Washington, DC: American Psychiatric
48. Potter LB, Rosenberg ML, Hammond WR. Suicide in youth: a public health
framework. J Am Acad Child Adolesc Psychiatry 1998;37:484-87.
49. Satcher D. Bringing the public health approach to the problem of suicide.
Suicide Life Threat Behav 1998;28:325-7.
Technical assistance and scientific consultation in the preparation of this
document was provided by the CDC, NIMH, Office of the Surgeon General and SAMHSA.
Support for its publication has been provided by the CDC, National Center for
Injury Prevention and Control. Support for the National Conference on Suicide
Prevention in Reno, Nevada, 1998, was provided in part by the Centers for
Disease Control and Prevention (National Center for Injury Prevention and
Control), the Health Resources and Services Administration, the National
Institute of Mental Health, and the Substance Abuse and Mental Health Services
Administration (Center for Mental Health Services).
Written by Lucy Davidson, MD, EdS; Lloyd Potter, PhD, MPH; and Virginia
In collaboration with Virginia Trotter Betts, MSN, JD, RN, FAAN; Alex
Crosby, MD, MPH; CDR Robert DeMartino, MD; Rodney Hammond, PhD; Kay Jamison,
PhD; Jane Pearson, PhD; RADM Darrel Regier, MD, Elsie Weyrauch, RN; and Gerald
Office of the Surgeon General scientific review and editing of this document
was provided by: RADM Susan J. Blumenthal, MD, MPA.
Members of the Conference Expert Panel: Morton M. Silverman, MD
(Chairperson); Alex Crosby, MD, MPH; Laurie Flynn; Dequincy A. Lezine; Jim
Moore; Jane Pearson, PhD; Leslie Scallet, JD; David Shaffer, MD; Scot Simpson;
Susan Soule, MA; Karl F. Weyrauch, MD, MPH.